CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating activities
Net loss	$ (6,817,343)	$ (5,319,190)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,317,203	1,308,776
Depreciation-Right of Use Assets - Financing	58,013	48,697
Stock based compensation	935,145	1,355,534
Amortization of financing fees	2,084	2,500
Provision (recovery) of doubtful accounts	322,320	20,086
Loss (gain) on marketable securities	(14,418)	377,475
Stock warrant expense	(8,598)	12,945
Derecognition of contingency and grant	0	(10,000)
Change in operating assets and liabilities:
Accounts receivable	1,913	(3,849,084)
Referral and support services agreement advance	150,000	150,000
Prepaid expenses, unbilled revenue and other assets	2,126	333,820
Accrued expenses and other liabilities	3,069,680	1,597,637
Accounts payable	(1,851,978)	1,401,820
Net cash used in operating activities	(2,833,853)	(2,568,984)
Investing activities:
Purchases of equipment and capitalized development costs	(836,428)	(911,443)
Purchase of marketable securities	0	(1,600,121)
Proceeds from the sale of marketable securities	2,288,873	1,155,912
Net cash provided by (used in) investing activities	1,452,445	(1,355,652)
Financing activities:
Gross proceeds from line of credit	592,868	0
Repayments on line of credit	(592,868)	0
Payments on finance lease obligations	(64,159)	(49,737)
Proceeds from at-the-market sales	61,136	0
Capital raise, net of issuance costs	3,665,000	0
Net taxes paid on restricted stock unit grants exercised	(166,872)	(128,521)
Net cash provided by/(used in) financing activities	3,495,105	(178,258)
Net change - cash	2,113,697	(4,102,894)
Cash and cash equivalent, beginning of year	2,931,415	10,475,964
Cash and cash equivalent, end of period	5,045,112	6,373,070
Supplemental information:
Interest paid	$ 67,532	$ 12,625